- Q1 6 %33.3
- Q2 12 %66.7
- Q3 0 %0.0
- Q4 0 %0.0
Academician
BAŞAK OYAN ULUÇ
Profesör
Acıbadem Mehmet Ali Aydınlar Üniversitesi
Research topics OpenAlex
- Lymphoma Diagnosis and Treatment5
- Viral-associated cancers and disorders4
- Cancer Treatment and Pharmacology3
- Multiple Myeloma Research and Treatments2
- Testicular diseases and treatments2
- Estrogen and related hormone effects2
- Hematopoietic Stem Cell Transplantation2
- Sarcoma Diagnosis and Treatment2
- CNS Lymphoma Diagnosis and Treatment2
- Breast Cancer Treatment Studies2
- Cardiac tumors and thrombi2
- Colorectal Cancer Treatments and Studies1
Academic summary
YÖKSİS and OpenAlex counted separately.
Articles
19
YÖKSİS19
OpenAlex0
Projects
0
Books
1
Proceedings
0
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 19 + YÖKSİS · co-author record: 43
h-index
14
Percentile in Türkiye: 85
#102 of 393 at their university by h-index
- i10-index
- 23
- Total citations
- 619 Top 18% in Türkiye
- Per article
- 10.0
- FWCI
- 0.78 1.00 = world average
- World top 1%
- 0
- World top 10%
- 3
Most cited articles
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 43 articles (312 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 34
- With an akaturk profile
- 0
- Turkish institutions
- 0
- Co-authored works
- %95
Academic co-authors 0
No co-author with an akaturk profile.
National collaboration 0 institutions
No joint work with another Turkish university.
Other co-authors (incl. international) 34
Oyan Basak 17Kansu Emin 6Koc Yener 6Kars Ayse 5Turker Alev 5Tekuzman Gulten 4Ozdemir Evren 3Altundag Kadri 2Ozturk Mehmet Akif 2Abalı HüseyinAkosman CAksoy SercanBarista IbrahimCanpinar HandeCinar VeyselDent SusanDikbas OguzEkici IDEmri SalihEngin HuseyinErcan SErdik BaranGüler NilüferHonig ArndHowell SachaKalayci MuratMano MaxOrdu COzisik YavuzOzveren OlcaySelcuk NAUsubutun AlpYalcin SuayibYavas Ozlem
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Index quartiles
?- Q1 3 %16.7
- Q2 3 %16.7
- Q3 9 %50.0
- Q4 3 %16.7
Top 1%0
Top 10%1
Avg · n 19
%55.2
Other counts
Scopus (SJR)
- YÖKSİS rows 18
WoS (JCR)
- YÖKSİS rows 18
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
15 journals
- Medical Oncology 3
- Cancer Treatment Reviews 2
- Acta Oncologica 1
- American Journal of Clinical Oncology: Cancer Clinical Trials 1
- Annals of Oncology 1
- Biology of Blood and Marrow Transplantation 1
- Blood Coagulation and Fibrinolysis 1
- Chemotherapy 1
- Clinical Transplantation 1
- Clinics and Research in Hepatology and Gastroenterology 1
- Expert Review of Anticancer Therapy 1
- Hematological Oncology 1
- International Journal of Hematology 1
- Leukemia and Lymphoma 1
- Medical Hypotheses 1
Narrow down
Article list
- 2013 Gallbladder perforation related to bevacizumab YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.4%
- 2013 Takotsubo syndrome YÖKSİS SJR Q2 JCR Q4 OpenAlex 89.1%
- 2013 HER2 targeted therapy in breast cancer A systematic review of neoadjuvant trials YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.2%
- 2012 Why do targeted agents not work in the adjuvant setting in colon cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.5%
- 2011 Potential role of bone directed therapy on the superiority of aromatase inhibitors over tamoxifen YÖKSİS SJR Q2 JCR Q3 OpenAlex 14.7%
- 2011 Unicentric mixed variant Castleman disease associated with Hashimoto disease the role of PET CT in staging and evaluating response to the treatment YÖKSİS OpenAlex 69.0%
- 2009 High complete remission rate and durable remissions achieved with rational use of autologous stem cell transplantation thalidomide maintenance and non myeloablative allogeneic transplantation in patients with multiple myeloma YÖKSİS SJR Q2 JCR Q2 OpenAlex 52.2%
- 2006 High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed refractory lymphoma YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.3%
- 2006 Improvement of Chronic Pulmonary Graft vs Host Disease Manifesting as Bronchiolitis Obliterans Organizing Pneumonia Following Extracorporeal Photopheresis YÖKSİS SJR Q2 JCR Q4 OpenAlex 70.1%
- 2006 Adding a single high dose chemotherapy cycle to three cycles of standard salvage chemotherapy for relapsed germ cell tumours does not improve clinical outcomes YÖKSİS SJR Q1 JCR Q2 OpenAlex 9.8%
- 2005 Ifosfamide Idarubicin and Etoposide in Relapsed Refractory Hodgkin Disease or Non Hodgkin Lymphoma A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.0%
- 2005 Alprazolam Significantly Improves the Efficacy of Granisetron in the Prophylaxis of Emesis Secondary to Moderately Emetogenic Chemotherapy in Patients with Breast Cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 74.9%
- 2005 Successful Salvage with High Dose Sequential Chemotherapy Coupled with In Vivo Purging and Autologous Stem Cell Transplantation in 2 Patients with Primary Refractory Mantle Cell Lymphoma Presenting in the Leukemic Phase YÖKSİS SJR Q2 JCR Q3 OpenAlex 56.6%
- 2005 Is it time to discontinue using high dose chemotherapy for salvage of patients with advanced germ cell tumors failing first line platinum chemotherapy YÖKSİS SJR Q1 JCR Q1 OpenAlex 16.4%
- 2004 Epithelioid Sarcoma of Vulva A Case Report and Review of the Literature YÖKSİS SJR Q2 JCR Q4 OpenAlex 62.5%
- 2004 Thymic malignancy in a breast cancer patient Is there an association with anti estrogenic effects of tamoxifen YÖKSİS SJR Q1 JCR Q3 OpenAlex 9.7%
- 2004 A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia YÖKSİS SJR Q1 JCR Q2 OpenAlex 10.9%
- 2004 Does Letrozole Have Any Place in Adjuvant Setting in Breast Cancer Patients With Documented Hypercoagulability YÖKSİS SJR Q2 JCR Q3 OpenAlex 63.2%
- 2002 Generalized Lymphadenopathy A Rare Presentation of Disseminated Prostate Cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.6%